Local injection of Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 significantly decreased stress-induced arrhythmias and prolonged the effective refractory period by about 30% in a rat model of chronic myocardial infarction.
Does local delivery of Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 reduce stress-induced arrhythmias in a rat model of chronic myocardial infarction?
Local injection of Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 ameliorates electromechanical competence and reduces arrhythmogenesis in a rat model of chronic myocardial infarction.
valor p: p=<0.05
Heart repair by stem cell treatment may involve life-threatening arrhythmias. Cardiac progenitor cells (CPCs) appear best suited for reconstituting lost myocardium without posing arrhythmic risks, being commissioned towards cardiac phenotype. In this study we tested the hypothesis that mobilization of CPCs through locally delivered Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 to heal chronic myocardial infarction (MI), lowers the proneness to arrhythmias. We used 133 adult male Wistar rats either with one-month old MI and treated with growth factors (GFs, n = 60) or vehicle (V, n = 55), or sham operated (n = 18). In selected groups of animals, prior to and two weeks after GF/V delivery, we evaluated stress-induced ventricular arrhythmias by telemetry-ECG, cardiac mechanics by echocardiography, and ventricular excitability, conduction velocity and refractoriness by epicardial multiple-lead recording. Invasive hemodynamic measurements were performed before sacrifice and eventually the hearts were subjected to anatomical, morphometric, immunohistochemical, and molecular biology analyses. When compared with untreated MI, GFs decreased stress-induced arrhythmias and concurrently prolonged the effective refractory period (ERP) without affecting neither the duration of ventricular repolarization, as suggested by measurements of QTc interval and mRNA levels for K-channel α-subunits Kv4.2 and Kv4.3, nor the dispersion of refractoriness. Further, markers of cardiomyocyte reactive hypertrophy, including mRNA levels for K-channel α-subunit Kv1.4 and β-subunit KChIP2, interstitial fibrosis and negative structural remodeling were significantly reduced in peri-infarcted/remote ventricular myocardium. Finally, analyses of BrdU incorporation and distribution of connexin43 and N-cadherin indicated that cytokines generated new vessels and electromechanically-connected myocytes and abolished the correlation of infarct size with deterioration of mechanical function. In conclusion, local injection of GFs ameliorates electromechanical competence in chronic MI. Reduced arrhythmogenesis is attributable to prolongation of ERP resulting from improved intercellular coupling via increased expression of connexin43, and attenuation of unfavorable remodeling.
Bocchi et al. (Fri,) conducted a other in Chronic myocardial infarction (n=133). Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 vs. Vehicle was evaluated on Stress-induced ventricular arrhythmias and effective refractory period (p=<0.05). Local injection of Hepatocyte Growth Factor and Insulin-Like Growth Factor-1 significantly decreased stress-induced arrhythmias and prolonged the effective refractory period by about 30% in a rat model of chronic myocardial infarction.